(No ratings)
Dr. Jennel Alexis Zeppieri, MD is a medical oncologist in Long Island City, NY specializing in medical oncology and physician. Dr. Jennel Alexis Zeppieri, MD is affiliated with NewYork-Presbyterian, Weill Cornell Medicine and Weill Cornell Medicine - Long Island City.
She is certified by the Board Certification: medical oncology and has a state license in New York.
Board Certification: Board Certification: medical oncology
Licensed In: New York
Dr. Jennel Alexis Zeppieri, MD appears to accept the following insurance providers: GHI, VNSNY CHOICE, Health Insurance Plan of NY (HIP), Oxford Health Plans, AETNA, Anthem Blue Cross/Blue Shield, Anthem Blue Cross/Blue Shield Healthplus, United Healthcare, Health Insurance Plan of New York (HIP), Group Health Incorporated (GHI), Aetna, Anthem, United Healthcare, Oxford Health Plans and Aetna - NYP.
According to our sources, Dr. Jennel Alexis Zeppieri, MD accepts the following insurance providers:
Dr. Jennel Alexis Zeppieri, MD does not have any reviews yet, be the first to leave a review of Dr. Jennel Alexis Zeppieri, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Jennel Alexis Zeppieri, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Novo Nordisk Inc |
$523
$523 |
|||||
|---|---|---|---|---|---|---|
| Celgene Corporation |
$125
Abraxane $125 |
|||||
| Daiichi Sankyo Inc. |
$86
Enhertu $86 |
|||||
| Amgen Inc. |
$45
Neulasta $16 |
LUMAKRAS $15 |
$14 |
|||
| GlaxoSmithKline, LLC. |
$44
ZEJULA $44 |
|||||
| Other |
$116
JAKAFI $29 |
NINLARO $15 |
OPDIVO $14 |
IMFINZI $14 |
PEMAZYRE $14 |
Other $30 |
| Grant | $523 |
|---|---|
| Food and Beverage | $416 |
Dr. Jennel Alexis Zeppieri is a board-certified medical oncologist and internist with a clinical focus on hereditary cancer syndromes, early detection, and cancer risk reduction. She completed both her fellowship in Hematology/Oncology—where she served as chief fellow—and her internal medicine residency—also as chief resident—at Robert Wood Johnson Barnabas Health.Dr. Zeppieri’s professional mission is deeply rooted in personal experience. Her mother’s diagnosis with BRCA-related pancreatic cancer sparked her passion for advancing care for individuals at high risk for cancer. This journey informs her commitment to compassionate, personalized care and her focus on increasing awareness of underrecognized hereditary cancer syndromes.Through her training and practice in diverse communities, Dr. Zeppieri has developed a nuanced understanding of how cultural values and individual preferences shape medical decision-making. She is committed to ensuring equitable access to preventive oncology care and advocates for strategies that integrate patient education, early detection, and multidisciplinary support.An active member of the American Society of Clinical Oncology and the American Society of Hematology, Dr. Zeppieri also serves on the executive board of the Student Movement Against Cancer. She has been recognized with awards for clinical compassion and research excellence, and she has presented on quality improvement initiatives and rare malignancies at national forums.